Quince Therapeutics, Inc. (QNCX)
31.32
+0.77
(+2.52%)
USD |
NASDAQ |
Sep 04, 16:00
31.18
-0.14
(-0.43%)
After-Hours: 20:00
Quince Therapeutics Total Assets (Quarterly) : 124.00M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 124.00M |
| March 31, 2026 | 26.62M |
| December 31, 2025 | 93.63M |
| September 30, 2025 | 109.90M |
| June 30, 2025 | 117.21M |
| March 31, 2025 | 107.09M |
| December 31, 2024 | 126.15M |
| September 30, 2024 | 126.52M |
| June 30, 2024 | 134.83M |
| March 31, 2024 | 159.29M |
| December 31, 2023 | 180.20M |
| September 30, 2023 | 85.39M |
| June 30, 2023 | 88.84M |
| March 31, 2023 | 93.32M |
| December 31, 2022 | 104.94M |
| Date | Value |
|---|---|
| September 30, 2022 | 109.78M |
| June 30, 2022 | 117.86M |
| March 31, 2022 | 116.13M |
| December 31, 2021 | 133.23M |
| September 30, 2021 | 147.42M |
| June 30, 2021 | 161.39M |
| March 31, 2021 | 174.52M |
| December 31, 2020 | 189.47M |
| September 30, 2020 | 204.66M |
| June 30, 2020 | 219.21M |
| March 31, 2020 | 231.20M |
| December 31, 2019 | 124.37M |
| September 30, 2019 | 133.41M |
| June 30, 2019 | 143.24M |
| March 31, 2019 | 70.60M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 2.112B |
| Oncolytics Biotech, Inc. | 7.671M |
| Sangamo Therapeutics, Inc. | 59.96M |
| Sarepta Therapeutics, Inc. | 3.189B |
| Anixa Biosciences, Inc. | 14.86M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 15.51M |
| Shareholders Equity (Quarterly) | 108.49M |
| Current Ratio | 14.52 |
| Net Debt Paydown Yield | 17.03% |